Breakthrough in Male Birth Control: Reversible, Non-Hormonal Pill Shows Promise

Researchers at Baylor College of Medicine have developed a compound that inhibits a key protein, offering a potential new method for male contraception.

The compound, CDD-2807, targets the protein STK33, essential for sperm function in men and mice.
In animal trials, CDD-2807 effectively reduced sperm motility and numbers without toxicity or long-term effects.
The contraceptive impact of CDD-2807 was found to be reversible, with normal fertility returning after discontinuation.
Further testing in primates is planned to evaluate the compound's effectiveness and safety for potential human use.
This development could expand contraceptive options, traditionally limited to condoms and vasectomies for men.